Weller J - Search Results

1

PCV chemotherapy alone for WHO grade 2 oligodendroglioma: prolonged disease control with low risk of malignant progression.

Weller J, Katzendobler S, Karschnia P, Lietke S, Egensperger R, Thon N, Weller M, Suchorska B, Tonn JC. Weller J, et al. Among authors: weller m. J Neurooncol. 2021 Jun;153(2):283-291. doi: 10.1007/s11060-021-03765-z. Epub 2021 May 1. J Neurooncol. 2021. PMID: 33932195 Free PMC article.

2

Prognostic value of O-(2-[¹⁸F]-fluoroethyl)-L-tyrosine PET in relapsing oligodendroglioma.

Schneider F, Wolpert F, Stolzmann P, Albatly AA, Kenkel D, Weller J, Weller M, Kollias SS, Rushing EJ, Veit-Haibach P, Huellner MW. Schneider F, et al. Among authors: weller m, weller j. Acta Oncol. 2020 Nov;59(11):1357-1364. doi: 10.1080/0284186X.2020.1787507. Epub 2020 Jul 20. Acta Oncol. 2020. PMID: 32686979

3

MRI and ¹⁸FET-PET Predict Survival Benefit from Bevacizumab Plus Radiotherapy in Patients with Isocitrate Dehydrogenase Wild-type Glioblastoma: Results from the Randomized ARTE Trial.

Wirsching HG, Roelcke U, Weller J, Hundsberger T, Hottinger AF, von Moos R, Caparrotti F, Conen K, Remonda L, Roth P, Ochsenbein A, Tabatabai G, Weller M. Wirsching HG, et al. Among authors: weller m, weller j. Clin Cancer Res. 2021 Jan 1;27(1):179-188. doi: 10.1158/1078-0432.CCR-20-2096. Epub 2020 Sep 23. Clin Cancer Res. 2021. PMID: 32967939 Free article. Clinical Trial.

4

Extent and prognostic value of MGMT promotor methylation in glioma WHO grade II.

Karschnia P, Teske N, Dorostkar MM, Siller S, Weller J, Baehring JM, Dietrich J, von Baumgarten L, Herms J, Tonn JC, Thon N. Karschnia P, et al. Among authors: weller j. Sci Rep. 2020 Nov 12;10(1):19758. doi: 10.1038/s41598-020-76312-x. Sci Rep. 2020. PMID: 33184319 Free PMC article.

5

Interstitial Photodynamic Therapy Using 5-ALA for Malignant Glioma Recurrences.

Lietke S, Schmutzer M, Schwartz C, Weller J, Siller S, Aumiller M, Heckl C, Forbrig R, Niyazi M, Egensperger R, Stepp H, Sroka R, Tonn JC, Rühm A, Thon N. Lietke S, et al. Among authors: weller j. Cancers (Basel). 2021 Apr 7;13(8):1767. doi: 10.3390/cancers13081767. Cancers (Basel). 2021. PMID: 33917116 Free PMC article.

6

Subventricular zone involvement is associated with worse outcome in glioma WHO grade 2 depending on molecular markers.

Karschnia P, Weller J, Blobner J, Stoecklein VM, Dorostkar MM, Rejeski K, Forbrig R, Niyazi M, von Baumgarten L, Dietrich J, Tonn JC, Thon N. Karschnia P, et al. Among authors: weller j. Sci Rep. 2021 Oct 8;11(1):20045. doi: 10.1038/s41598-021-97714-5. Sci Rep. 2021. PMID: 34625590 Free PMC article.

7

Extent, pattern, and prognostic value of MGMT promotor methylation: does it differ between glioblastoma and IDH-wildtype/TERT-mutated astrocytoma?

Teske N, Karschnia P, Weller J, Siller S, Dorostkar MM, Herms J, von Baumgarten L, Tonn JC, Thon N. Teske N, et al. Among authors: weller j. J Neurooncol. 2022 Jan;156(2):317-327. doi: 10.1007/s11060-021-03912-6. Epub 2021 Dec 13. J Neurooncol. 2022. PMID: 34902093 Free PMC article.

8

Diagnostic Yield and Complication Rate of Stereotactic Biopsies in Precision Medicine of Gliomas.

Katzendobler S, Do A, Weller J, Dorostkar MM, Albert NL, Forbrig R, Niyazi M, Egensperger R, Thon N, Tonn JC, Quach S. Katzendobler S, et al. Among authors: weller j. Front Neurol. 2022 Mar 30;13:822362. doi: 10.3389/fneur.2022.822362. eCollection 2022. Front Neurol. 2022. PMID: 35432168 Free PMC article.

9

Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3.

Weller J, Katzendobler S, Blobner J, Thiele F, Becker H, Quach S, Egensperger R, Niyazi M, Suchorska B, Thon N, Weller M, Tonn JC. Weller J, et al. Among authors: weller m. J Neurooncol. 2022 Oct;160(1):149-158. doi: 10.1007/s11060-022-04128-y. Epub 2022 Sep 16. J Neurooncol. 2022. PMID: 36112301 Free PMC article.

10

TSPO PET signal using [¹⁸F]GE180 is associated with survival in recurrent gliomas.

Quach S, Holzgreve A, Kaiser L, Unterrainer M, Dekorsy FJ, Nelwan DV, Bartos LM, Kirchleitner SV, Weller J, Weidner L, Niyazi M, Ruf VC, Herms J, Stöcklein S, Wetzel C, Riemenschneider MJ, V Baumgarten L, Thon N, Brendel M, Rupprecht R, Bartenstein P, Tonn JC, Albert NL. Quach S, et al. Among authors: weller j. Eur J Nucl Med Mol Imaging. 2023 Feb;50(3):859-869. doi: 10.1007/s00259-022-06006-1. Epub 2022 Nov 4. Eur J Nucl Med Mol Imaging. 2023. PMID: 36329288 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

878 results

Search Page

Filters